Immunomodulation

DBCAT005064Pharmacologic class

Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. A DrugBank category of 2 drugs. 2 of them are approved.

Drugs: Axicabtagene ciloleucel
Brexucabtagene autoleucel

What you can answer from here — as of July 19, 2019

2DrugsEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

9Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Immunomodulation share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account